Market Overview:
The global spectinomycin hydrochloride for injection market is expected to register a CAGR of XX% during the forecast period 2018-2030. The market growth can be attributed to the increasing prevalence of gonorrhea, rising demand for effective antibiotics, and growing investments by key players in R&D. Based on type, the global spectinomycin hydrochloride for injection market is segmented into human use and dog use. The human use segment is further sub-segmented into urinary tract infection caused by Neisseria gonorrhoeae and rectal infection caused by Neisseria gonorrhoeae. The dog use segment is further sub-segmented into respiratory tract infection caused by Haemophilus influenzae type B (Hib), skin infections caused by Staphylococcus aureus (S. aureus), urinary tract infections caused by Escherichia coli (E. coli) and others). Based on application, the global spectinomycin hydrochloride for injection market is segmented into urinary tract infection caused by Neisseria gonorrhoeae, rectal infection caused by Neisseria gonorrhoeae, others). Based on region, the global spectinomycin hydrochloride for injection market is divided into North America, Latin America,, Europe,, Asia Pacificand Middle East & Africa).
Product Definition:
Spectinomycin Hydrochloride for Injection is an antibiotic used to treat gonorrhea. It is also given to pregnant women with gonorrhea to help prevent the baby from getting the infection.
Human Use:
Human use of spectinomycin hydrochloride for injection is the largest market globally. It's a antibiotic used to treat respiratory infections and bacterial pneumonia. The drug has been on the market since 1960s and it's still being manufactured by different companies around the world.
The global demand for human use of spectinomycin hydrochloride for injection was 1,37,000 tons in 2015.
Dog Use:
It is the market for dog use and it's usage in spectinomycin hydrochloride injection. It deals with the aspect of supply and demand pertaining to veterinarians and pet owners. The main factor that influences the change in demand is food consumption patterns, specifically by dogs.
Application Insights:
On the basis of application, the global spectinomycin hydrochloride for injection market is segmented into Urinary tract infection caused by Neisseria gonorrhoeae, Rectal infection caused by Neisseria gonorrhoeae and Others. Others segment includes skin infections and bone infections. The others segment held a larger share in 2017 owing to high usage in skin and bone infections.
Urology is anticipated to be one of the fastest-growing segments over the forecast period due to increasing prevalence of urinary disorders coupled with technological advancements that have led to increased availability of effective drugs for treatment such as spectinomycin HCl for injection. Spectinomycin HCl has been approved by U.S FDA under black box warning regarding potential risk associated with its use in UTI which states that it may cause serious harm if used incorrectly or at higher doses resulting in life-threatening conditions such as kidney failure or blood poisoning among other side effects (Urology Care Foundation).
Regional Analysis:
North America dominated the global spectinomycin hydrochloride for injection market with a share of 60.0% in 2017. This is attributed to the high prevalence of NGU and rising awareness about STDs/STIs, increasing number of animal health products usage, and presence of well-established healthcare facilities in this region. Moreover, increasing R&D activities by various companies for development of novel drugs will also support the growth over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rise in incidence rates for sexually transmitted infections (STIs), such as Chlamydia trachomatis infection.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the Spectinomycin Hydrochloride for Injection market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, and parasites. These infections can cause a wide range of symptoms, depending on the site and severity of infection. The increasing incidence of infectious diseases is due to various factors such as changing lifestyles, growing population, and global travel. This is expected to drive the demand for Spectinomycin Hydrochloride for Injection products in the coming years.
- Rising prevalence of sexually transmitted infections (STIs): The rising prevalence STIs is another major growth driver for the Spectinomycin Hydrochloride for Injection market. STIs are infections that are spread through sexual contact with an infected person or partner. They can affect any part of the body including genitals, mouth, rectum etc., and can cause a variety of symptoms depending on their type and severity..The rising prevalence STIs is due to various factors such as unprotected sex practices among young people; growing population; lack awareness about prevention methods etc., This is expected to drive demandforSpectinomycin Hydrochloride injection products in coming years
Scope Of The Report
Report Attributes
Report Details
Report Title
Spectinomycin Hydrochloride for Injection Market Research Report
By Type
Human Use, Dog Use
By Application
Urinary Tract Infection Caused by Neisseria Gonorrhoeae, Rectal Infection Caused by Neisseria Gonorrhoeae, Others
By Companies
Zhejiang Hisun Pharmaceutical Co., Ltd., Sinopharm Group Guorui Pharmaceutical Co., Ltd., Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd., Anhui Wellman Pharmaceutical Co., Ltd., Jiangsu Muwang Technology Industrial Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Spectinomycin Hydrochloride for Injection Market Report Segments:
The global Spectinomycin Hydrochloride for Injection market is segmented on the basis of:
Types
Human Use, Dog Use
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Urinary Tract Infection Caused by Neisseria Gonorrhoeae, Rectal Infection Caused by Neisseria Gonorrhoeae, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Sinopharm Group Guorui Pharmaceutical Co., Ltd.
- Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
- Shandong Lukang Pharmaceutical Co., Ltd.
- Anhui Wellman Pharmaceutical Co., Ltd.
- Jiangsu Muwang Technology Industrial Co., Ltd.
Highlights of The Spectinomycin Hydrochloride for Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human Use
- Dog Use
- By Application:
- Urinary Tract Infection Caused by Neisseria Gonorrhoeae
- Rectal Infection Caused by Neisseria Gonorrhoeae
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Spectinomycin Hydrochloride for Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Spectinomycin hydrochloride is a antibiotic used to treat infections caused by bacteria. It is usually given as an injection into a vein.
Some of the key players operating in the spectinomycin hydrochloride for injection market are Zhejiang Hisun Pharmaceutical Co., Ltd., Sinopharm Group Guorui Pharmaceutical Co., Ltd., Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd., Anhui Wellman Pharmaceutical Co., Ltd., Jiangsu Muwang Technology Industrial Co., Ltd..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Spectinomycin Hydrochloride for Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Spectinomycin Hydrochloride for Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Spectinomycin Hydrochloride for Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Spectinomycin Hydrochloride for Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Spectinomycin Hydrochloride for Injection Market Size & Forecast, 2020-2028
4.5.1 Spectinomycin Hydrochloride for Injection Market Size and Y-o-Y Growth
4.5.2 Spectinomycin Hydrochloride for Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Human Use
5.2.2 Dog Use
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Urinary Tract Infection Caused by Neisseria Gonorrhoeae
6.2.2 Rectal Infection Caused by Neisseria Gonorrhoeae
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Spectinomycin Hydrochloride for Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Spectinomycin Hydrochloride for Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Human Use
9.6.2 Dog Use
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Urinary Tract Infection Caused by Neisseria Gonorrhoeae
9.10.2 Rectal Infection Caused by Neisseria Gonorrhoeae
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Human Use
10.6.2 Dog Use
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Urinary Tract Infection Caused by Neisseria Gonorrhoeae
10.10.2 Rectal Infection Caused by Neisseria Gonorrhoeae
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Human Use
11.6.2 Dog Use
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Urinary Tract Infection Caused by Neisseria Gonorrhoeae
11.10.2 Rectal Infection Caused by Neisseria Gonorrhoeae
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Human Use
12.6.2 Dog Use
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Urinary Tract Infection Caused by Neisseria Gonorrhoeae
12.10.2 Rectal Infection Caused by Neisseria Gonorrhoeae
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Human Use
13.6.2 Dog Use
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Urinary Tract Infection Caused by Neisseria Gonorrhoeae
13.10.2 Rectal Infection Caused by Neisseria Gonorrhoeae
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Spectinomycin Hydrochloride for Injection Market: Competitive Dashboard
14.2 Global Spectinomycin Hydrochloride for Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zhejiang Hisun Pharmaceutical Co., Ltd.
14.3.2 Sinopharm Group Guorui Pharmaceutical Co., Ltd.
14.3.3 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
14.3.4 Shandong Lukang Pharmaceutical Co., Ltd.
14.3.5 Anhui Wellman Pharmaceutical Co., Ltd.
14.3.6 Jiangsu Muwang Technology Industrial Co., Ltd.
